Oct-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Chime & Chill has demonstrated a notable performance in the Topical category within New York. In August 2024, the brand climbed to the third position, a significant achievement considering it wasn't in the top 30 in July. This upward trajectory was maintained into October, where it held steady at the third spot, indicating a consistent demand for its products in this category. Despite the absence of ranking in September, the brand's sales figures suggest a return to form by October, highlighting a robust recovery and sustained consumer interest.
However, it's important to note that Chime & Chill's absence from the top 30 in both July and September could be seen as an area of concern or a potential opportunity for growth in those months. The brand's ability to regain its position in October suggests resilience and adaptability in the competitive landscape of New York's cannabis market. Such fluctuations could be attributed to seasonal trends, marketing strategies, or shifts in consumer preferences, but without more detailed data, it remains speculative. This performance pattern might provide strategic insights for the brand to leverage in future market planning and expansion efforts.
Competitive Landscape
In the competitive landscape of the New York topical cannabis market, Chime & Chill has shown fluctuating performance in recent months. While consistently ranking third in August and October 2024, the brand was absent from the top 20 in July and September, indicating potential volatility in its market presence. This inconsistency contrasts with the stable performance of competitors like Ayrloom, which has maintained a dominant first-place position throughout the same period, and Veterans Choice Creations (VCC), which has consistently held the second rank. The sales figures for Chime & Chill also reflect this instability, with noticeable gaps in reported sales during months when the brand did not rank. This suggests that while Chime & Chill has the potential to compete with leading brands, it may need to address underlying issues to achieve more consistent sales and ranking performance in the New York market.
Notable Products
In October 2024, the CBD/CBN 2:1 PM Lotion (300mg CBD, 150mg CBN) maintained its top position in the rankings for Chime & Chill, continuing its unbroken streak from previous months with sales reaching 171 units. The CBD/CBG 2:1 AM Cream (300mg CBD, 150mg CBG) improved its rank to second place, moving up from third, with a notable increase in sales to 90 units. The CBD/CBN 2:1 PM Oral Solution 10-Pack (200mg CBD, 100mg CBN) slipped to third place, despite consistent sales figures. Meanwhile, the CBD/THC Calm & Chill PM Bath Salts (100mg CBD, 100mg THC) remained steady in fourth place, showing a significant rise in sales compared to previous months. New to the list, the CBD/CBN 1:1 PM Spa Soak (100mg CBD, 100mg CBN) debuted in fifth place, marking its initial entry into the rankings.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.